The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).

Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!

Resource Search

Search Results

TRIO Study Brief:  Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think

TRIO Study Brief: Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think

RTI International | Women’s Global Health Imperative; Impact Research and Development Organization, Kenya; Setshaba Research Centre, South Africa; The Initiative for MPTs (IMPT) February 2021
Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion April 2019 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): MPTs Product Development Product Trials

Dellplain, L., Young Holt, B., Hemmerling, A., Romano, J., van der Straten, A., & Turpin, J. Visit Technical Brief April 2019
Market Access Framework for MPT Development

Market Access Framework for MPT Development

This framework is intended to serve as a resource to inform product development and investment decision-making that is focused specifically on market access components of MPT development and introduction—in other words, activities that are critical to ensuring that MPTs in development are not only efficacious in clinical trials, but also desired, acceptable, and accessible to […]

(IMPT) Initiative for Multipurpose Prevention Technologies Visit Technical Brief April 2019
2017 IMPT Annual Report

2017 IMPT Annual Report

2017 IMPT Annual Report March 2018 click to view Report In this Report: Topic(s): Advocacy Collective Impact MPTs

Visit Annual March 2018
Status of Modelling Efforts in the Field of Multipurpose Prevention Technologies: Summary Report

Status of Modelling Efforts in the Field of Multipurpose Prevention Technologies: Summary Report

Status of Modelling Efforts in the Field of Multipurpose Prevention Technologies: Summary Report February 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): ARVs IVR (Intravaginal Rings) MPTs Vaginal Cream/Gel Vaginal Film Topic(s): Collective Impact Education MPTs Risk

Dellplain, L., Polis, C., & Royal, D. Visit Technical Brief February 2017
Join the MPT development collaboration

Join the MPT development collaboration

Join the MPT development collaboration November 2017 click to view Technical Brief In this Technical Brief: Topic(s): Product Development SRH Linkages Region(s): Global Working Group(s): (SAWG) Scientific Agenda Working Group

CAMI Health Visit Technical Brief November 2017
Hormonal contraceptive eligibility for women at high risk of HIV. Guidance Statement

Hormonal contraceptive eligibility for women at high risk of HIV. Guidance Statement

Hormonal contraceptive eligibility for women at high risk of HIV. Guidance Statement 01 March 2017 click to view Report In this Report: Health Risk(s): Unintended Pregnancy Product Type(s): Hormonal Contraceptives Topic(s): Reproductive Health

[No authors listed]. Visit Reports March 2017
Traditional Socio-Behavioral Research and Human-Centered Design: Similarities, Unique Contributions and Synergies

Traditional Socio-Behavioral Research and Human-Centered Design: Similarities, Unique Contributions and Synergies

This report by Dr. Betsy Tolley (FHI 360) presents learnings and reflections on traditional socio-behavioral research (SBR) and human-centered design (HCD) as applied to the global health context – specifically in biomedical prevention for sexual and reproductive health. In comparing these methodologies and examining their strengths and shortcomings, we can identify potential synergies to further […]

Tolley, E.B., FHI 360 December 2017
The importance of sexual and reproductive health and rights to prevent HIV in adolescent girls and young women in eastern and southern Africa

The importance of sexual and reproductive health and rights to prevent HIV in adolescent girls and young women in eastern and southern Africa

The importance of sexual and reproductive health and rights to prevent HIV in adolescent girls and young women in eastern and southern Africa 01 January 2017 click to view Report In this Report: Health Risk(s): HIV Topic(s): Advocacy Reproductive Health Social/Behavioral Context SRH Linkages

[no authors listed] Visit Reports January 2017
Family Planning. Evidence Brief. Expanding contraceptive choice

Family Planning. Evidence Brief. Expanding contraceptive choice

Family Planning. Evidence Brief. Expanding contraceptive choice 31 January 2017 click to view Report In this Report: Health Risk(s): Unintended Pregnancy Topic(s): Reproductive Health

[no authors listed] Visit Reports January 2017
2016 IMPT Annual Report

2016 IMPT Annual Report

2016 IMPT Annual Report April 2017 The IMPT’s second Annual Report highlights another year of the Initiative’s accomplishments. This includes an overview of the year’s technical convenings, task force work in Kenya, the IMPT’s role in numerous conferences, as well as work toward market access coordination, and other points of potential interest. Building from 2015, […]

Stewart, K. April 2017
MPTs: Building momentum through awareness-raising and advocacy

MPTs: Building momentum through awareness-raising and advocacy

MPTs: Building momentum through awareness-raising and advocacy July 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Advocacy Education Product Development Social/Behavioral Context Region(s): Global

Kilbourne-Brook, M. Visit Technical Brief July 2017
Building capacity for MPT product development

Building capacity for MPT product development

Building capacity for MPT product development July 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Policy Product Development Public-Private Partnerships Regulatory Issues Region(s): Global

Kilbourne-Brook, M. Visit Technical Brief July 2017
Building MPT acceptability during product development through consumer and health systems research

Building MPT acceptability during product development through consumer and health systems research

Building MPT acceptability during product development through consumer and health systems research July 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Product Development Product Introduction / Uptake Public-Private Partnerships Regulatory Issues Social/Behavioral Context Region(s): Global

Kilbourne-Brook, M. Visit Technical Brief July 2017
Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries

Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries

Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries October 2017 Building upon the IMPT’s report: “Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development,” the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in […]

October 2017

Contraception for HIV-infected Adolescents

Contraception for HIV-infected Adolescents August 2016 click to view Report In this Report: Health Risk(s): Unintended Pregnancy Product Type(s): Contraceptives Topic(s): Reproductive Health

Kourtis, A., & Mirza, A. Visit Reports August 2016
Clinical Trial Evaluation Workshop for MPTs: Strategic Steps to Ensure Success

Clinical Trial Evaluation Workshop for MPTs: Strategic Steps to Ensure Success

Clinical Trial Evaluation Workshop for MPTs: Strategic Steps to Ensure Success 13-14 September 2016 Washington, DC, USA click to view Technical Brief In this Technical Brief: Topic(s): Product Trials

Visit Technical Brief September 2016

What’s next for the Woman’s Condom? Celebrating a successful conclusion to the POW PDP

What’s next for the Woman’s Condom? Celebrating a successful conclusion to the POW PDP January 2016 click to view Report In this Report: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms Contraceptives Topic(s): MPTs Product Development Reproductive Health

[No authors listed] Visit Reports January 2016
2015 IPM Annual Report: New Hope for Women’s HIV Prevention

2015 IPM Annual Report: New Hope for Women’s HIV Prevention

2015 IPM Annual Report: New Hope for Women’s HIV Prevention September 2016 click to view Report In this Report: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): MPTs

[No authors listed] Visit Reports September 2016

Understanding the Potential for Multipurpose Prevention fo Pregnancy and HIV: Results from surveys assessing four hypothetical concept profiles of Multipurpose Prevention Technologies (MPTs) in Uganda, Nigeria, and South Africa

Understanding the Potential for Multipurpose Prevention fo Pregnancy and HIV: Results from surveys assessing four hypothetical concept profiles of Multipurpose Prevention Technologies (MPTs) in Uganda, Nigeria, and South Africa 2016 click to view Report In this Report: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Contraceptives MPTs Topic(s): MPTs Reproductive Health SRH Linkages

El-Sahn, M., Lucas, J., Aikenhead, M., Nemade, R., & Van Damme, L. Visit Reports January 2016
Sixty-Ninth World Health Assembly. Draft global health sector strategies – Sexually transmitted infections, 2016-2021

Sixty-Ninth World Health Assembly. Draft global health sector strategies – Sexually transmitted infections, 2016-2021

Sixty-Ninth World Health Assembly. Draft global health sector strategies – Sexually transmitted infections, 2016-2021 16 May 2016 click to view Report In this Report: Health Risk(s): STI / STD

WHO Secretariat Visit Reports May 2016
2016 Pipeline Report. HIV and TB. Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development

2016 Pipeline Report. HIV and TB. Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development

2016 Pipeline Report. HIV and TB. Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development 15 July 2016 click to view Report In this Report: Health Risk(s): HIV Product Type(s): Vaccines Topic(s): Advocacy Education

Clayden, P., Collins, S., Frick, M., Harrington, M., Horn, T., Jefferys, R., Lessem, E., & McKenna, L. Visit Reports July 2016
2015 IMPT Annual Report

2015 IMPT Annual Report

2015 IMPT Annual Report April 2016 The IMPT’s inaugural Annual Report highlights the Initiative’s accomplishments in 2015 and our recent progress toward making MPTs a reality. It also gives an overview of the current MPT product pipeline and reports on global MPT investments. As you read through the Annual Report, we hope you will consider […]

Stewart, K., Vyda, L. April 2016
AVAC Report 2016 – Big Data Real People

AVAC Report 2016 – Big Data Real People

AVAC Report 2016 – Big Data Real People July 2016 click to view Report In this Report: Topic(s): Advocacy

[No authors listed] Visit Reports July 2016
Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development

Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development

Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development 30 September 2016 This report outlines the methodology and results of an IMPT Secretariat project that was funded by USAID’s Office of HIV/AIDS, the objective of which was to create the foundation for a Strategic Evaluation Framework (SEF) for […]

Dellplain, L. & Thomas, V. September 2016
Technical Meeting on Hormonal Contraception (HC) in MPTs

Technical Meeting on Hormonal Contraception (HC) in MPTs

Technical Meeting on Hormonal Contraception (HC) in MPTs 12 September 2016 Washington, DC, USA click to view Report In this Report: Product Type(s): ARVs Contraceptives MPTs Topic(s): Product Development Product Trials

Visit Reports September 2016

Biomedical AIDS research: recent and upcoming advance

Biomedical AIDS research: recent and upcoming advance 2015 click to view Report In this Report: Health Risk(s): HIV STI / STD Product Type(s): Microbicides Vaccines Other or N/A Topic(s): Epidemiology

[No authors listed]. Visit Reports January 2015
Research and Development of New Biomedical HIV Prevention Tools for Women and Girls: Combating the Global AIDS Epidemic Through a More Empowered Response in Sub-Saharan Africa

Research and Development of New Biomedical HIV Prevention Tools for Women and Girls: Combating the Global AIDS Epidemic Through a More Empowered Response in Sub-Saharan Africa

Research and Development of New Biomedical HIV Prevention Tools for Women and Girls: Combating the Global AIDS Epidemic Through a More Empowered Response in Sub-Saharan Africa September 2015 click to view Report In this Report: Health Risk(s): HIV Product Type(s): Vaccines Topic(s): Product Development

[No authors listed] Visit Reports September 2015
2015 IMPT Joint Steering Committee & SACC Meeting

2015 IMPT Joint Steering Committee & SACC Meeting

2015 IMPT Joint Steering Committee & SACC Meeting June 2015 click to view Report In this Report: Topic(s): Collective Impact Funding MPTs Product Development Product Introduction / Uptake Region(s): Global Working Group(s): (SACC) Supporting Agency Collaboration Committee

CAMI Health Visit IMPT June 2015

WHO Statement on Public Disclosure of Clinical Trial Results

WHO Statement on Public Disclosure of Clinical Trial Results 2015 click to view Report In this Report: Health Risk(s): Other Product Type(s): Other or N/A Topic(s): Policy Product Trials

[No authors listed]. Visit Reports January 2015

Microbicide Development Hinges on New Products Administered in New Ways

Microbicide Development Hinges on New Products Administered in New Ways 2015 click to view Report In this Report: Health Risk(s): HIV Product Type(s): ARVs IVR (Intravaginal Rings) Microbicides Vaginal Film Topic(s): MPTs Product Development Product Trials

Rushton, M. Visit Reports January 2015
Round Table on Commercialization and Social-Behavioral Issues for MPTs

Round Table on Commercialization and Social-Behavioral Issues for MPTs

Round Table on Commercialization and Social-Behavioral Issues for MPTs 17 March 2015 Bethesda, MD, USA Held at the Annual MTN Meeting, this round table session examined the complex commercialization and social-behavioral (CSB) issues related to successful MPT development and guide the prioritization of CSB activities. The convening focused particularly on end-user perspectives, service delivery, and […]

CAMI Health March 2015
2014 IPM Annual Report: The Promise of Prevention for Women

2014 IPM Annual Report: The Promise of Prevention for Women

2014 IPM Annual Report: The Promise of Prevention for Women 2015 click to view Report In this Report: Health Risk(s): Other Product Type(s): Other or N/A Topic(s): Reproductive Health

[No authors listed]. Visit Reports January 2015

HIV, HCV, TB: 2015 Pipeline Report

HIV, HCV, TB: 2015 Pipeline Report 17 July 2016 click to view Report In this Report: Health Risk(s): Hepatitis HIV Product Type(s): Vaccines Topic(s): Product Development

[No authors listed]. Visit Reports July 2015
HIV Prevention Research & Development Funding Trends, 2000-2014: Investing in innovation in an evolving global health and development landscape

HIV Prevention Research & Development Funding Trends, 2000-2014: Investing in innovation in an evolving global health and development landscape

HIV Prevention Research & Development Funding Trends, 2000-2014: Investing in innovation in an evolving global health and development landscape July 2015 click to view Report In this Report: Health Risk(s): HIV Product Type(s): HIV Treatment Microbicides MPTs Vaccines Topic(s): Funding MPTs Product Development

[No authors listed] Visit Reports July 2015